tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ATHE Stock Latest News

Buy Rating for Alterity Therapeutics: Strong Financial Position and Promising Clinical Results
RatingsBuy Rating for Alterity Therapeutics: Strong Financial Position and Promising Clinical Results
3d ago
ATHE
Alterity Therapeutics Announces Change in Substantial Holding
PremiumCompany Announcements
Alterity Therapeutics Announces Change in Substantial Holding
13d ago
6K
ATHE
Alterity Therapeutics Expands Capital with New Securities Quotation
PremiumCompany Announcements
Alterity Therapeutics Expands Capital with New Securities Quotation
14d ago
6K
ATHE
Alterity Therapeutics Issues Over 1 Billion New Shares
PremiumCompany Announcements
Alterity Therapeutics Issues Over 1 Billion New Shares
14d ago
6K
ATHE
Alterity Therapeutics raises A$40M in placement
PremiumThe Fly
Alterity Therapeutics raises A$40M in placement
22d ago
ATHE
Alterity Therapeutics Ltd (ADR) trading halted, news pending
PremiumThe FlyAlterity Therapeutics Ltd (ADR) trading halted, news pending
27d ago
ATHE
Alterity Therapeutics downgraded to Hold from Speculative Buy at Benchmark
Premium
The Fly
Alterity Therapeutics downgraded to Hold from Speculative Buy at Benchmark
29d ago
ATHE
Alterity Therapeutics price target raised to $12 from $8 at Maxim
Premium
The Fly
Alterity Therapeutics price target raised to $12 from $8 at Maxim
1M ago
ATHE
Alterity Therapeutics announces ATH434 Phase 2 trial results
PremiumThe Fly
Alterity Therapeutics announces ATH434 Phase 2 trial results
1M ago
ATHE
Alterity Therapeutics Ltd (ADR) trading halted, news pending
PremiumThe Fly
Alterity Therapeutics Ltd (ADR) trading halted, news pending
1M ago
ATHE
Alterity Therapeutics reports cash balance of A$4.54M as of December 31
PremiumThe Fly
Alterity Therapeutics reports cash balance of A$4.54M as of December 31
1M ago
ATHE
Alterity Therapeutics Expands ASX Quoted Securities
PremiumCompany Announcements
Alterity Therapeutics Expands ASX Quoted Securities
1M ago
6K
ATHE
Alterity Therapeutics Reports Key Advances and Anticipates Milestones in 2025
PremiumCompany AnnouncementsAlterity Therapeutics Reports Key Advances and Anticipates Milestones in 2025
1M ago
6K
ATHE
Alterity CEO says ‘filled with optimism for 2025’
Premium
The Fly
Alterity CEO says ‘filled with optimism for 2025’
2M ago
ATHE
Alterity Therapeutics initiated with a Buy at Maxim
Premium
The Fly
Alterity Therapeutics initiated with a Buy at Maxim
3M ago
ATHE
Alterity Therapeutics completes last patient visit in ATH434-201 trial
PremiumThe Fly
Alterity Therapeutics completes last patient visit in ATH434-201 trial
3M ago
ATHE
Alterity Therapeutics appoints Abby Macnish Niven as secretary
PremiumThe Fly
Alterity Therapeutics appoints Abby Macnish Niven as secretary
4M ago
ATHE
Alterity Therapeutics announces presentation on bioMUSE study
PremiumThe Fly
Alterity Therapeutics announces presentation on bioMUSE study
4M ago
ATHE
Alterity Therapeutics announces new publication on ATH434
PremiumThe Fly
Alterity Therapeutics announces new publication on ATH434
4M ago
ATHE
Alterity Therapeutics reports cash balance of A$9.28M as of September 30
PremiumThe FlyAlterity Therapeutics reports cash balance of A$9.28M as of September 30
4M ago
ATHE
Alterity Therapeutics to Present at Healthcare Summit
Premium
Company Announcements
Alterity Therapeutics to Present at Healthcare Summit
5M ago
6K
ATHE
Alterity Therapeutics presents data on neuroprotection of ATH434
Premium
The Fly
Alterity Therapeutics presents data on neuroprotection of ATH434
5M ago
ATHE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >